Arabian Pharmaceuticals plans to sell 10.49% stake in Al-Daweya

GIB Capital Company announced the launch of the book-building process to sell approximately 10.49% of Al-Dawaa Pharmacy, which is owned by Arab Pharmaceuticals and Medical Supplies Company. The sale will involve up to 12.588 million shares to institutional investors. The aim of this process is to raise additional capital and improve the company's liquidity. This offering is part of the company's efforts to strengthen its presence and expand its strategic footprint in the pharmaceutical market.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل